Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof
Abstract
An alkyl ether derivative represented by the following general formula [1] or its salt: wherein R 1 and R 2 represent each a substituent such as hydrogen, halogeno or alkyl; R 3 represents alkylamino, amino or hydroxyl; the ring A represents a 5- or 6-membered aromatic heterocycle or a benzene ring; m and n are each an integer of from 1 to 6; and p is an integer of from 1 to 3; shows an effect of protecting retinal nerve cells and, therefore, is useful as a preventive and/or a remedy for retinal nerve diseases such as glaucoma, diabetic retinopathy, retinal artery obstruction, retinal venous obstruction, macular degeneration and retinopathy of prematurity.
Claims
exact text as granted — not AI-modified1 . A preventive and/or remedy for retinal nerve diseases characterized in that it comprises an alkyl ether derivative represented by the following general formula [1]:
wherein R 1 and R 2 , which may be the same or different, each represents one or more groups selected from a hydrogen atom, a halogen atom, a substituted or unsubstituted alkyl, aryl, aralkyl, alkoxy, aryloxy, alkylthio, arylthio, alkenyl, alkenyloxy, amino, alkylsulfonyl, arylsulfonyl, carbamoyl or heterocyclic group, a protected or unprotected amino, hydroxyl or carboxyl group, a nitro group and an oxo group; R 3 represents a substituted or unsubstituted alkylamino group, or a protected or unprotected amino or hydroxyl group; the ring A represents a 5- or 6-membered aromatic heterocyclic ring or a benzene ring; m and n each represents an integer between 1 and 6; and p represents an integer between 1 and 3; or a salt thereof.
2 . The preventive and/or remedy for retinal nerve diseases according to claim 1 , wherein the portion represented by the following formula:
of the alkyl ether derivative represented by the general formula [1] according to claim 1 is any one of the following (A), (B), and (C):
3 . The preventive and/or remedy for retinal nerve diseases according to claim 1 , wherein R 1 represents a hydrogen atom; and R 2 represents a hydrogen atom, a halogen atom or an alkoxy group.
4 . The preventive and/or remedy for retinal nerve diseases according to claim 1 , wherein m represents 2; n represents an integer of 2 or 3; and p represents an integer of 1 or 2.
5 . The preventive and/or remedy for retinal nerve diseases according to claim 2 , wherein R 1 represents a hydrogen atom; and R 2 represents a hydrogen atom, a halogen atom or an alkoxy group.
6 . The preventive and/or remedy for retinal nerve diseases according to claim 2 , wherein m represents 2; n represents an integer of 2 or 3; and p represents an integer of 1 or 2.
7 . The preventive and/or remedy for retinal nerve diseases according to claim 3 , wherein m represents 2; n represents an integer of 2 or 3; and p represents an integer of 1 or 2.Join the waitlist — get patent alerts
Track US2006205709A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.